Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

被引:1
作者
Won, Ho-Ryun [1 ,2 ]
Kim, Min Gyu [1 ]
Kim, Min Soo [1 ]
Chang, Jae Won [1 ,3 ]
Koo, Bon Seok [1 ,3 ]
机构
[1] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Sejong Hosp, Sejong, South Korea
[3] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
thyroid cancer; papillary thyroid microcarcinoma; active surveillance; recurrence; clinical factor; BRAF MUTATION; CANCER; ASSOCIATION; CARCINOMA;
D O I
10.1530/ETJ-23-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Active surveillance (AS) has been suggested as a management option for low-risk papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria for AS application do not consider various clinical factors. The purpose of this study was to analyze clinical factors related to recurrence that could be confirmed preoperatively in patients who underwent surgery for PTMC and to identify factors worth considering when deciding whether to apply AS. Materials and methods: Data were collected from patients with PTMC who underwent surgical treatment at Chungnam National University Hospital. A retrospective cohort was established according to the presence or absence of recurrence during the follow-up period. In total, 2717 patients were enrolled, of whom 60 experienced recurrence. Various clinical factors that could be identified before surgery were analyzed. Results: The relationship between various clinical factors that could be confirmed preoperatively and recurrence was confirmed through Cox regression analysis and Kaplan-Meier curve analysis. BRAF mutation and the tall cell variant were significantly more common in patients with recurrence. In patients aged 55 years or older, the risk of recurrence was lower than in younger patients, while the recurrence-free survival (RFS) rate was higher. Conclusion: When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Proteomic analysis of the papillary thyroid microcarcinoma
    Jin, Shan
    Bao, Wuyuntu
    Yang, Yun-Tian
    Fu, Quan
    Bai, Yinbao
    Liu, Yousheng
    ANNALES D ENDOCRINOLOGIE, 2019, 80 (5-6) : 293 - 300
  • [22] Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension
    Kwon, Ohjoon
    Lee, Sohee
    Bae, Ja Seong
    GLAND SURGERY, 2023, 12 (09) : 1179 - 1190
  • [23] Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients
    Qian, Kai
    Guo, Kai
    Zheng, Xiaoke
    Sun, Tuanqi
    Li, Duanshu
    Wu, Yi
    Ji, Qinghai
    Wang, Zhuoying
    ONCOTARGET, 2017, 8 (39) : 65836 - 65846
  • [24] Active surveillance is an excellent management technique for identifying patients with progressive low- risk papillary thyroid microcarcinoma requiring surgical treatment
    Fujishima, Makoto
    Miyauchi, Akira
    Ito, Yasuhiro
    Kudo, Takumi
    Noda, Takuya
    Sano, Tsutomu
    Sasaki, Takahiro
    Kishi, Taketoshi
    Nakamura, Tomohiko
    ENDOCRINE JOURNAL, 2023, 70 (04) : 411 - 418
  • [25] Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients
    Song, Jianlu
    Yan, Ting
    Qiu, Wangwang
    Fan, Youben
    Yang, Zhili
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2523 - 2530
  • [26] Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)
    Moon, Jae Hoon
    Kim, Ji-hoon
    Lee, Eun Kyung
    Lee, Kyu Eun
    Kong, Sung Hye
    Kim, Yeo Koon
    Jung, Woo-jin
    Lee, Chang Yoon
    Yoo, Roh-Eul
    Hwangbo, Yul
    Song, Young Shin
    Kim, Min Joo
    Cho, Sun Wook
    Kim, Su-jin
    Jung, Eun Jae
    Choi, June Young
    Ryu, Chang Hwan
    Lee, You Jin
    Hah, Jeong Hun
    Jung, Yuh-Seog
    Ryu, Junsun
    Hwang, Yunji
    Park, Sue K.
    Sung, Ho Kyung
    Yi, Ka Hee
    Park, Do Joon
    Park, Young Joo
    ENDOCRINOLOGY AND METABOLISM, 2018, 33 (02) : 278 - 286
  • [27] Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
    Ito, Y.
    Miyauchi, A.
    Oda, H.
    EJSO, 2018, 44 (03): : 307 - 315
  • [28] Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?
    Liu, Qi
    Song, Mingyuan
    Zhang, Hao
    JOURNAL OF CANCER, 2024, 15 (04): : 1009 - 1020
  • [29] Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly
    Wang, Xiaofei
    Lei, Jianyong
    Wei, Tao
    Zhu, Jingqiang
    Li, Zhihui
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2371 - 2377
  • [30] Papillary thyroid microcarcinoma: toward an active surveillance strategy
    Molinaro, Eleonora
    Campopiano, Maria Cristina
    Elisei, Rossella
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (01) : R23 - R34